Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Aspen Aerogels (ASPN) Shares Outstanding (Diluted Average) (2020 - 2025)

Aspen Aerogels' Shares Outstanding (Diluted Average) history spans 6 years, with the latest figure at $82.3 million for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) rose 2.52% year-over-year to $82.3 million, compared with a TTM value of $82.3 million through Dec 2025, up 2.52%, and an annual FY2025 reading of $82.3 million, up 2.52% over the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $82.3 million at Aspen Aerogels, roughly flat from $82.2 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $82.3 million in Q4 2025, with the low at $28.2 million in Q2 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $61.0 million, with a median of $69.3 million recorded in 2023.
  • Year-over-year, Shares Outstanding (Diluted Average) skyrocketed 109.97% in 2023 and then increased 2.52% in 2025.
  • Tracing ASPN's Shares Outstanding (Diluted Average) over 5 years: stood at $30.4 million in 2021, then rose by 29.34% to $39.4 million in 2022, then skyrocketed by 76.41% to $69.4 million in 2023, then grew by 15.65% to $80.3 million in 2024, then rose by 2.52% to $82.3 million in 2025.
  • Per Business Quant, the three most recent readings for ASPN's Shares Outstanding (Diluted Average) are $82.3 million (Q4 2025), $82.2 million (Q3 2025), and $82.1 million (Q2 2025).